share_log

Citigroup Downgrades Core Laboratories to Sell, Lowers Price Target to $21

Benzinga ·  Jun 30, 2023 06:39

Citigroup analyst Scott Gruber downgrades Core Laboratories (NYSE:CLB) from Neutral to Sell and lowers the price target from $22 to $21.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment